Renal prostaglandin E2 receptor (EP) expression profile is altered in streptozotocin and B6-Ins2Akita type I diabetic mice. (Q52573334)

3 May 2018

title

Renal prostaglandin E2 receptor (EP) expression profile is altered in streptozotocin and B6-Ins2Akita type I diabetic mice. (English)

1 reference

3 May 2018

1 reference

Rania Nasrallah

1

1 reference

3 May 2018

Huaqi Xiong

series ordinal

2

1 reference

3 May 2018

Richard L Hébert

series ordinal

3

1 reference

3 May 2018

publication date

5 September 2006

1 reference

3 May 2018

American Journal of Physiology - Renal Physiology

published in

1 reference

3 May 2018

volume

292

1 reference

3 May 2018

issue

1

1 reference

3 May 2018

page(s)

F278-84

1 reference

3 May 2018

The Ins2Akita mouse as a model of early retinal complications in diabetes

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00089.2006

Preventing renal complications in diabetic patients: the Diabetics Exposed to Telmisartan And enalaprIL (DETAIL) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00089.2006

Genotoxicity of streptozotocin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00089.2006

Segmental synthesis and actions of prostaglandins along the nephron

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00089.2006

Nephron number and renal risk in hypertension and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00089.2006

Prostaglandin E receptors and the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00089.2006

Angiotensin II and its receptors in the diabetic kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00089.2006

Cyclooxygenase-2 inhibitor blocks expression of mediators of renal injury in a model of diabetes and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00089.2006

Eicosanoids in the pathogenesis of the functional and structural alterations of the kidney in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00089.2006

Impact of genetic background on nephropathy in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00089.2006

Complications of IgA nephropathy in a non-insulin-dependent diabetes model, the Akita mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00089.2006

Functional and molecular aspects of prostaglandin E receptors in the cortical collecting duct.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00089.2006

Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00089.2006

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00089.2006

Renal cyclooxygenase-2 in obese Zucker (fatty) rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00089.2006

Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00089.2006

Differential expression of aquaporins in the kidneys of streptozotocin-induced diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00089.2006

Prevention of diabetic nephropathy in rats by prostaglandin E receptor EP1-selective antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00089.2006

p38 MAP kinase mediates mechanically induced COX-2 and PG EP4 receptor expression in podocytes: implications for the actin cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00089.2006

Prostanoid receptors: structures, properties, and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00089.2006

Reduced IP receptors in STZ-induced diabetic rat kidneys and high-glucose-treated mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00089.2006

Characterization of the PGI2/IP system in cultured rat mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00089.2006

Increased expression of cyclooxygenase-1 and -2 in the diabetic rat renal medulla

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00089.2006

The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00089.2006

Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00089.2006

The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00089.2006

The prostaglandin E2 analogue sulprostone antagonizes vasopressin-induced antidiuresis through activation of Rho.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00089.2006

COX-2 inhibition and prostaglandin receptors in experimental nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00089.2006

Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00089.2006

10.1152/AJPRENAL.00089.2006

21 January 2018

Identifiers

DOI

1 reference

3 May 2018

PubMed ID

16954344

1 reference

3 May 2018